High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123
Carolyn A. Buser(United States Military Academy), Kenneth S. Koblan(Sumitomo Dainippon Pharma (United States)), Eileen S. Walsh(Janssen (Switzerland)), Theresa M. Williams(United States Military Academy), Scott D. Mosser(United States Military Academy), Christopher J. Dinsmore(United States Military Academy), Ian Greenberg(United States Military Academy), Christine Fernandes(United States Military Academy), Kelly Hamilton(United States Military Academy)
Cited by 30
Related Papers
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|Blood|2020|167
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|157
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP
|Bioorganic & Medicinal Chemistry Letters|2005|137
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues
|Proceedings of the National Academy of Sciences|2006|119
3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
|Journal of Medicinal Chemistry|2002|86